We will be performing scheduled website maintenance August 26th and 27th which may briefly disrupt access to the APhA Foundation website.

To receive information about the APhA Foundation and its programs, or to register for the 2017 Pinnacle Awards and Lecture, please contact info@aphafoundation.org.

ALZHEIMER'S DISEASE: COGNITIVE MEMORY SCREENING AND REFERRAL PROGRAM

The Background

The Background

Pharmacists have a unique opportunity to identify and manage individuals with AD and other cognitive memory disorders. The Cognitive Memory Screening and Referral Program (CMSRP) is the first project to measure the impact of a pharmacist-based cognitive memory screening service delivered in community pharmacy practice in the United States. While the involvement of community pharmacists in the screening of AD is novel in the US and across the globe, there are several studies supporting community pharmacists having a significant role in screening of diseases. 
 

Key Objectives

  1. Evaluate the impact of pharmacy-based cognitive memory screening on outcomes of referral of at-risk patients to their primary care physician.
  2. Measure patient satisfaction with advanced clinical services and the willingness of patients to pay for cognitive memory screening services.

 

>LEARN ABOUT THE PARTICIPANTS

<RETURN TO MAIN PROJECT PAGE